Qiagen N.V. (ETR:QIA)

Market Cap	8.93B
Revenue (ttm)	1.76B
Net Income (ttm)	345.50M
Shares Out	n/a
EPS (ttm)	1.57
PE Ratio	25.84
Forward PE	19.59
Dividend	1.42 (3.45%)
Ex-Dividend Date	Jul 2, 2025

Volume	260,923
Average Volume	523,479
Open	41.47
Previous Close	41.45
Day's Range	41.13 - 41.60
52-Week Range	34.24 - 47.36
Beta	0.68
RSI	59.60
Earnings Date	Nov 4, 2025

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1984
• Employees: 5,396
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: QIA

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD